WHO vaccine-preventable diseases: monitoring system. 2020 global summary

Last updated 15-July-2020 (data as of 12-October-2020)
Next overall update End 2020

Select a country


Development status:	Economy in transition	GNI / capita (US$):	6'280¹	Infant (under 12 months) mortality rate:	3²
Development status:	Economy in transition	GDP / capita (US$):	19'943¹	Child (under 5 years) mortality rate:	4²

					2019	2018	2017	2016	2015	2000	1990	1980

Population data in thousands³
Total population					9'452	9'453	9'450	9'446	9'439	9'872	10'151	9'570
Births					110	111	113	114	115	88	142	155
Surviving infants					109	111	113	114	114	87	140	152
Pop. less than 5 years					556	566	575	581	578	457	787	738
Pop. less than 15 years					1'610	1'594	1'579	1'560	1'535	1'829	2'328	2'181
Female 15-49 years					2'180	2'203	2'228	2'255	2'285	2'619	2'468	2'492

Number of reported cases							(Click for retrospective incidence data for Belarus)
Diphtheria					0	0	0	0	0	52	22	_
Japanese encephalitis					0	0	0	0	_	_	_	_
Measles***					201	259	1	10	2	21	224	_
Mumps					8	1	4	4	3	19'069	_	_
Pertussis					776	648	516	522	503	169	462	_
Polio*					0	0	0	0	0	0	_	_
Rubella***					0	0	1	0	1	16'034	_	_
Rubella (CRS)					0	0	0	0	0	0	_	_
Tetanus (neonatal)					0	0	0	0	0	0	_	_
Tetanus (total)**					0	_	0	0	0	1	_	_
Yellow fever					0	0	0	0	_	0	_	_
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]). Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system. * For 2019, if a country did not submit a joint reporting form, measles and rubella cases were sourced from data reported through the monthly surveillance data available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/

Percentage target population vaccinated by antigen							Hovering over an antigen reveals its fuller definition
	Most recent coverage survey⁴					Official country estimates⁵
							(Click for retrospective coverage estimates data for Belarus)
Vaccine	year	result	method	% card seen
BCG					97	98	98	98	97	99	_	_
DTP1					98	98	97	99	99	_	_	_
DTP3					98	97	97	98	99	99	_	_
IPV1					98	98	98	99	99	_	_	_
HepB_BD					98	98	98	98	98	_	_	_
HepB3					97	98	98	96	99	70	_	_
Hib3					91	67	99	97	98	_	_	_
JapEnc					_	_	_	_	_	_	_	_
MCV1					98	98	97	98	99	98	_	_
MCV2					98	98	98	98	99	92	_	_
MenA					_	_	_	_	_	_	_	_
PCV1					99*	98	99	97	99*	_	_	_
PCV2					99*	97	98	97	96	_	_	_
PCV3					99	98	98	99	99	_	_	_
Pol3					98	98	98	98	99	99	_	_
Rota1					_	_	_	_	_	_	_	_
RotaC					_	_	_	_	_	_	_	_
RCV1					98	98	97	98	99	_	_	_
TT2plus					_	_	_	_	_	_	_	_
PAB					_	_	_	_	_	_	_	_
VAD1					_	_	_	_	_	_	_	_
YFV					_	_	_	_	_	_	_	_
* indicates the country reported above 100% coverage.

			Next update: Mid July 2021			WHO-UNICEF estimates⁶
							(Click for full retrospective WHO-UNICEF coverage estimates data for Belarus)
BCG					97	98	98	98	97	99	_	_
DTP1					98	98	97	99	99	99	_	_
DTP3					98	97	97	98	99	99	_	_
HepB3					97	98	98	96	99	70	_	_
HepB_BD					98	98	98	98	98	_	_	_
Hib3					91	67	9	11	9	_	_	_
IPV1					98	98	98	99	99	_	_	_
MCV1					98	98	97	98	99	98	_	_
MCV2					98	98	98	98	99	92	_	_
PCV3					_	_	_	_	_	_	_	_
Pol3					98	98	98	98	99	99	_	_
RCV1					98	98	97	98	99	98	_	_
RotaC					_	_	_	_	_	_	_	_

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country	130	Proportion of districts reporting DTP3 coverage:
% of coverage reports received at national level vs number of reports expected	100

/ \| \| \
	Greater or equal to 90%	100
	From 80 to 89%	0
	From 50 to 79%	0
	Less than 50%	0
Proportion of districts not reporting DTP3 coverage		0

Vaccine	Schedule	Entire country	Comment

Immunization Schedule^{(2019 or latest available)}		Hovering over an antigen reveals its fuller definition
aP		Yes	children who have contraindications to the administration of vaccines containing whole-cell pertussis component
BCG	3-5 days;	Yes
Diphteria	11 years;	Yes	anatoxin diphtheria purified adsorbed with reduced antigen content
DT	6 years;	Yes
DTwP	18 months;	Yes
DTwPHibHepB	2, 3, 4 months;	Yes
HepA_Adult		No	epidemiological indications and vaccination of individual cohorts of the population in certain regions in accordance with the decision of local authorities (not included in the National Calendar)
HepA_Pediatric		No	epidemiological indications and vaccination of individual cohorts of the population in certain regions in accordance with the decision of local authorities (not included in the National Calendar)
HepB_Pediatric	1 day;	Yes	newborns in the first 12 hours of life
HIB	1-4 years;	Yes	for children who have not previously received prophylactic vaccinations agagins hemophilic infections until 5 years of age, and having a specified chronic condition
Influenza_Adult	>65 years;	Yes	and adults with chronic conditions, pregnant women, healthcare workers, residents living in long-term care facilities, other risk groups
Influenza_Pediatric	6 months-3 years;	Yes	and children with chronic conditions
IPV	2, 3, 4 months; 7 years;	Yes
MMR	1, 6 years;	Yes
Pneumo_conj	2, 4, 12 months;	Yes	children <5 years with specific chonic conditions/diseases
TBE		Yes	epidemic indications
Td	16, 26, 36, 46, 56, 66 years;	Yes
TT		Yes	emergency tetanus prophylaxis
YF		Yes	epidemic vaccination

Indicator	Expected answer	2019	2018	2017	2016	2015	2014	2013

Immunization indicators

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization?	Yes/No/NR	No	No	No	No	No	No	Yes
What years does the MYP cover?	number							2007-2012

System performance

Total Nº districts in country	number	130	130	130	121	121	131	121
Nº districts with DTP3 coverage >=80%	number	130	130	130	121	121	121	121
% of districts with DTP3 coverage >=80%	From 0 to 100%	100	100	100	100	100	92	100
Nº districts with measles (MCV1) coverage >=95%	number	130	130	130	121	121	121	121
% of districts with MCV1 coverage >=95%	From 0 to 100%	100	100	100	100	100	92	100

Safety

Has the country a vaccine adverse events review committee?	Yes/No/NR/ND	No	No	No	Yes	Yes	Yes	Yes
Is there a national system to monitor adverse events following immunization (AEFI)?	Yes/No/NR	Yes	Yes	Yes	Yes	Yes	Yes	Yes

Finance

% of Immunization expenditure financed, using Government funds?	From 0 to 100%		NA	58			NA

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)?	Yes/No/NR	Yes	Yes	Yes	Yes	Yes	Yes	Yes

Sources

1 "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.

2 UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)

3 "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.

4 UNICEF/WHO survey database

5 If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.

6 WHO-UNICEF estimates.

WHO vaccine-preventable diseases: monitoring system. 2020 global summary

Select a country

Population data in thousands3

Number of reported cases

Percentage target population vaccinated by antigen

Official country estimates5

WHO-UNICEF estimates6

Immunization Schedule (2019 or latest available)

Immunization indicators

Sources

Population data in thousands³

Official country estimates⁵

WHO-UNICEF estimates⁶

Immunization Schedule^{(2019 or latest available)}